Mayo’s Franklyn Prendergast dies at 78
Dr. Franklyn Prendergast, former Director of the Mayo Clinic Comprehensive Cancer Center, dies at 78.
Menu
Menu
From articles in Forbes to podcast featuring Steve Gorlin, see our latest news here
Dr. Franklyn Prendergast, former Director of the Mayo Clinic Comprehensive Cancer Center, dies at 78.
Article recently published in Forbes explains the role of SCR-3 in regulating T cell suppression
Drug Target Review’s Taylor Mixides exclusively interviewed David Lonard, PhD, Chief Scientific Officer at CoRegen and Associate Professor at Baylor University, to uncover the mechanisms of SRC-3 and why it’s key to targeting cancer – and only cancer. See full interview below or at Drug Target Review
Dr. Benz, former president and chief executive officer of Dana-Farber Cancer Institute, joins CoRegen’s Board of Directors, bringing more than three decades of expertise in oncology research and cancer care